17-47253892-T-C

Variant summary

Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM3PP4_StrongPM2_SupportingPS3

This summary comes from the ClinGen Evidence Repository: The c.31T>C (p.Trp11Arg) missense variant has been reported in at least 3 probands (PMIDs: 25728920, 28748566, 25373348), at least one of whom (PMID:25728920) meets criteria for PP4_Strong; including mucocutaneous bleeding, impaired aggregation with all agonists except ristocetin, and reduced surface expression of αIIbβ3 measured by flow cytometry. Two homozygotes (PM3) and one compound heterozygote (with Likely Pathogenic Cys486Trp variant) has been observed. It is absent from controls in gnomADv2.1.1 (PM2_supporting. The expression of αIIbβ3 on the surface of HEK cells was evaluated by flow cytometry and showed no detectable αlIbβ3 protein (PMID:36122578; PS3). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Glanzmann thrombasthenia. GT-specific criteria applied: PS3, PM2_supporting, PM3, and PP4_strong. LINK:https://erepo.genome.network/evrepo/ui/classification/CA291240306/MONDO:0010119/011

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000038 ( 0 hom. )

Consequence

ITGB3
NM_000212.3 missense

Scores

2
6
10

Clinical Significance

Pathogenic reviewed by expert panel P:2U:1

Conservation

PhyloP100: 0.891
Variant links:
Genes affected
ITGB3 (HGNC:6156): (integrin subunit beta 3) The ITGB3 protein product is the integrin beta chain beta 3. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in platelets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 11 ACMG points.

PS3
PM2
PM3
PP4

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ITGB3NM_000212.3 linkuse as main transcriptc.31T>C p.Trp11Arg missense_variant 1/15 ENST00000559488.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ITGB3ENST00000559488.7 linkuse as main transcriptc.31T>C p.Trp11Arg missense_variant 1/151 NM_000212.3 P1P05106-1
ITGB3ENST00000571680.1 linkuse as main transcriptc.31T>C p.Trp11Arg missense_variant 1/91
ITGB3ENST00000696963.1 linkuse as main transcriptc.31T>C p.Trp11Arg missense_variant 1/14 P05106-2

Frequencies

GnomAD3 genomes
AF:
0.00000659
AC:
1
AN:
151742
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000376
AC:
44
AN:
1169378
Hom.:
0
Cov.:
30
AF XY:
0.0000370
AC XY:
21
AN XY:
568196
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000456
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000659
AC:
1
AN:
151742
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74152
show subpopulations
Gnomad4 AFR
AF:
0.0000242
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000340

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2Uncertain:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Glanzmann thrombasthenia Pathogenic:1
Pathogenic, reviewed by expert panelcurationClinGen Platelet Disorders Variant Curation Expert Panel, ClinGenNov 02, 2023The c.31T>C (p.Trp11Arg) missense variant has been reported in at least 3 probands (PMIDs: 25728920, 28748566, 25373348), at least one of whom (PMID: 25728920) meets criteria for PP4_Strong; including mucocutaneous bleeding, impaired aggregation with all agonists except ristocetin, and reduced surface expression of αIIbβ3 measured by flow cytometry. Two homozygotes (PM3) and one compound heterozygote (with Likely Pathogenic Cys486Trp variant) has been observed. It is absent from controls in gnomADv2.1.1 (PM2_supporting. The expression of αIIbβ3 on the surface of HEK cells was evaluated by flow cytometry and showed no detectable αlIbβ3 protein (PMID: 36122578; PS3). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Glanzmann thrombasthenia. GT-specific criteria applied: PS3, PM2_supporting, PM3, and PP4_strong. -
Glanzmann thrombasthenia 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 12, 2024Variant summary: ITGB3 c.31T>C (p.Trp11Arg) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. c.31T>C has been reported in the literature in individuals affected with Glanzmann Thrombasthenia 2 (Sandrock-Lang_2015, Nurden_2015, Waxman_2022). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function shows that the variant does not affect protein biosynthesis, but affects the transport of the protein to the membrane (Waxman_2022). The following publications have been ascertained in the context of this evaluation (PMID: 25728920, 36122578, 25373348, 27469266). ClinVar contains an entry for this variant (Variation ID: 953028). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJul 26, 2022This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 11 of the ITGB3 protein (p.Trp11Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of ITGB3 -related bleeding disorders (PMID: 25373348, 25728920). ClinVar contains an entry for this variant (Variation ID: 953028). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.47
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Uncertain
-0.030
CADD
Benign
19
DANN
Benign
0.82
DEOGEN2
Uncertain
0.47
T;.
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.30
T;T
M_CAP
Uncertain
0.20
D
MetaRNN
Pathogenic
0.77
D;D
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;.
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.97
N;.
Sift
Uncertain
0.011
D;.
Sift4G
Benign
0.28
T;T
Polyphen
0.44
B;.
Vest4
0.65
MutPred
0.70
Gain of disorder (P = 0);Gain of disorder (P = 0);
MVP
0.90
MPC
0.90
ClinPred
0.23
T
GERP RS
2.3
Varity_R
0.31
gMVP
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1022839092; hg19: chr17-45331258; API